A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Soham D. Puvvada, José M. Guillén-Rodríguez, Xavier I. Rivera, Kara Heard, Lora Inclan, Monika Schmelz, Jonathan H. Schatz, Daniel O. Persky

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences